Choosing antibodies against drug metabolising enzymes: why a cyp2c9 antibody and a cyp2e1 antibody must be shown not to cross-react within a family that shares most of its sequence, what microsomal preparation the blot needs, and why activity assays usually answer the question better
The cytochrome P450 family is the hardest case for antibody specificity in routine use, because its members share most of their sequence and differ in the regions that matter. An antibody raised against a conserved stretch will report the whole family, and nothing about the band size will tell you. This page covers what evidence to demand and when an activity measurement is the better experiment.
- the preparation that concentrates a membrane enzyme for a blot
- microsomes
- the family evidence that is the specification for this target class
- cross-reactivity
- the authentication guidance a funded study is expected to follow
- NIH rigor
Figures in this panel are the validation and labelling rules a research antibody is bought and used under, named from the guidance itself and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Specifying and controlling the reagent
- Demand cross-reactivity data against the family, by name. The useful evidence is a panel of recombinant family members blotted side by side, showing the antibody detects one and not the others. A datasheet naming only the intended target has not addressed the question that matters for this family.
- Prepare microsomes rather than whole lysate. These enzymes sit in the endoplasmic reticulum membrane, so a microsomal preparation concentrates them substantially against soluble protein. It is a centrifugation step and it usually makes more difference than any change of antibody.
- Do not over-denature a membrane enzyme. As with other membrane proteins, hard boiling promotes aggregation. A lower denaturation temperature is worth testing before concluding the reagent does not work, and a lane that shows material stuck in the well is the diagnostic.
- Use recombinant enzyme as the positive and a null system as the negative. Single-enzyme recombinant preparations are widely available and make an unambiguous positive control. A system expressing none of the family is the corresponding negative, and together they settle specificity far better than tissue alone.
- Consider whether activity is the real question. A selective probe substrate measured by chromatography reports what the enzyme does, which is usually what a study needs, and it distinguishes family members by their catalytic selectivity rather than by an epitope. Protein level and activity frequently diverge.
Induction studies and what they need
Where the question is whether a compound induces an enzyme, both protein and activity should move together and transcript usually moves first. Measuring all three across a time course is what makes an induction claim defensible.
Include a known inducer as a positive control at a known concentration. Induction experiments without one cannot distinguish a compound that does not induce from an assay that would not have detected it.
Species differences are large here
The family differs substantially between species in both membership and substrate selectivity, so an antibody validated in human material may detect nothing, or something else, in a model organism. Ask for tested rather than predicted reactivity.
The same caution applies to extrapolating biology: a metabolic route in one species is frequently not the route in another, which is the whole reason these measurements are made.
Buying and recording
Prefer a monoclonal or recombinant reagent with published cross-reactivity data, buy one lot for a study, and record the catalogue number and lot with every experiment. Polyclonal reagents against this family are particularly prone to lot variation in their cross-reactivity.
Keep the recombinant enzyme controls in the freezer alongside. Re-checking specificity when a new lot arrives takes one gel and removes the largest uncertainty in the measurement.
Common questions
- How do I know a cyp2c9 antibody is specific?
- By a blot of recombinant family members side by side showing detection of the target and not its close relatives. Within this family, sequence identity is high enough that specificity has to be demonstrated rather than assumed.
- Why is my signal weak in liver lysate?
- Whole lysate dilutes a membrane enzyme with abundant soluble protein. Prepare microsomes, and check the denaturation temperature, because these enzymes aggregate when boiled hard.
- Should I measure protein or activity?
- Activity, usually. A selective probe substrate measured by chromatography reports function and distinguishes family members catalytically. Protein level and activity diverge often enough that the choice matters.
- Can these antibodies be used for immunohistochemistry?
- Some are validated for it, and the same cross-reactivity question applies with less ability to check by size. Ask for staining in a tissue with a known expression pattern and, ideally, alongside a null control.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/drug-metabolism-antibodies/.